Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04158297 · ClinicalTrials.gov registry record · NA

ESWL Versus SOPIL for Treatment of Pancreatic Duct Stones

A NA study of Chronic Pancreatitis and Pancreatic Duct Stone, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04158297 is a NA study of Chronic Pancreatitis and Pancreatic Duct Stone that has completed, run by Indiana University. The registered enrollment target is 30 participants, below the 688-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04158297, a NA study of Chronic Pancreatitis and Pancreatic Duct Stone, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Pancreatic duct stones can cause obstruction of the main pancreatic duct leading to abdominal pain, exocrine pancreatic insufficiency, and recurrent acute pancreatitis. By removing pancreatic duct stones, the obstruction can be relieved, and this can improve symptoms. Small stones can be removed with standard endoscopic retrograde cholangiopancreatography (ERCP) and stone removal, but larger stones may require lithotripsy to break up the stone before removal. The two current methods of lithotripsy include extracorporeal shock wave lithotripsy (ESWL) and single operator pancreatoscopy with intracorporeal lithotripsy (SOPIL). ESWL is based on concentrating shock wave energy to the stone through an external device. SOPIL is a newer technique based on direct visualization of the stone during ERCP and targeting the stone with a shock wave catheter. There are currently no studies directly comparing ESWL to SOPIL for breaking apart stones in the pancreatic duct, so this study is designed to compare the two techniques. Objective #1: Obtain pilot data to determine the optimal method of clearing large MPDS Objective #2: Obtain pilot data to assess how effective large MPDS clearance is in improving long term patient centered outcomes Objective #3: Obtain pilot data to measure the cost effectiveness of large MPDS clearance

Interventions

  • PROCEDURE ESWL vs SOPIL

Study Locations (1)

Indiana

  • Indiana University Health Hospital - Indianapolis

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2019-11-13
Est. Completion 2025-09-05
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT04158297

The ClinicalTrials.gov registry entry for NCT04158297 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 688-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (96% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Pancreatitis appearing as the primary indexed condition, and to 1 intervention - of which ESWL vs SOPIL is the first listed.

NCT04158297 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT04158297 about?

NCT04158297 is a clinical study titled "ESWL Versus SOPIL for Treatment of Pancreatic Duct Stones". Pancreatic duct stones can cause obstruction of the main pancreatic duct leading to abdominal pain, exocrine pancreatic insufficiency, and recurrent acute pancreatitis. By removing pancreatic duct stones, the obstruction can be relieved, and this can improve symptoms. Small stones can be removed wit...

What is the current status of trial NCT04158297?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-11-13. Estimated completion is 2025-09-05.

What conditions does trial NCT04158297 study?

This clinical trial studies the following conditions: Chronic Pancreatitis, Pancreatic Duct Stone.

What interventions are being tested in trial NCT04158297?

The interventions under investigation include: ESWL vs SOPIL (PROCEDURE).

Who is sponsoring clinical trial NCT04158297?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04158297 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pancreatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.